FDA.reportPublic FDA data

Application 209471

Type
NDA
Sponsor
AFT PHARMS US

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001COMBOGESICACETAMINOPHEN; IBUPROFENTABLET;ORAL325MG;97.5MGYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80347SUPPL 2024-11-25
80326SUPPL 2024-11-22
80325SUPPL 2024-11-22
77689ORIG 2024-03-01
73654ORIG 2023-03-02
73653ORIG 2023-03-01